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Abstract The Ras-GRF1 exchange factor molecule contains in
addition to the catalytic domain two pleckstrin homology (PH1
and PH2), one IQ and one Dbl homology (DH) domains. In this
study we investigated the role of such additional domains. We
found that a Ras-GRF1 mutant lacking PH1 and IQ domains is
sufficient to activate c-fos promoter in response to lysophos-
phatidic acid (LPA). The same mutant did not increase external
stimuli-regulated kinase (ERK) activity, suggesting an additional
mechanism for the induction of gene transcription. Isolated DH-
PH2 module activates c-Jun NH2-terminal kinase and the c-fos
promoter in response to LPA, providing the basis for an ERK-
independent mechanism. These results provide evidence that Ras-
GRF1 acts as a bifunctional molecule on both ERK-dependent
and independent pathways.
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1. Introduction
Ras proteins function as molecular switches, cycling be-
tween active GTP-bound and inactive GDP-bound states.
They are activated by guanine nucleotide exchange factors
(GEFs) which in turn are regulated by extracellular signals.
In mammalians three classes of Ras-speci¢c GEFs have been
characterized. Sos proteins are ubiquitously expressed and
their involvement in coupling growth factor receptors to
Ras-dependent signaling pathways is well understood [1^3].
Ras-GRF1, or Cdc25Mm [4^6], is the prototype of the second
class, that also includes Ras-GRF2 [7]. Ras-GRF1 is ex-
pressed postnatally in brain neurons [8,9] and appears to
play a role in long term memory formation [10]. It induces
Ras signaling in response to calcium in£ux [11] and to acti-
vated G protein-coupled receptors [12^14]. Recently a third
type of Ras exchange factor called Ras-GRP has been de-
scribed containing calcium and diacylglycerol-binding motifs
[15].
Ras-GRFs and Sos have similar Ras-GEF catalytic do-
mains and both contain a Dbl homology (DH)-pleckstrin ho-
mology (PH) module [16]. Ras-GRFs contain in addition an
N-terminal PH domain followed by a putative coiled coil and
a calcium calmodulin-binding motif (IQ) [11].
Recently the DH domains of Sos and of Ras-GRF2 have
been reported to be associated with Rac-speci¢c exchange
activity [17,18], while no activity toward Rho family of small
GTPases has been reported for DH domain of Ras-GRF1
[19]. However Rac1-speci¢c GEF activity has been recently
reported for Ras-GRF1 when expressed together with G pro-
tein LQ subunits [20].
We have previously shown that in ¢broblasts, ectopically
expressing Ras-GRF1, lysophosphatidic acid (LPA) stimu-
lates the activation of the c-fos promoter and of external
stimuli-regulated kinase 1 (ERK1) much more e⁄ciently
than in parental NIH-3T3 cells. This e¡ect is abrogated by
the expression of the dominant negative RasN17 mutant and
of the N-terminal region of Ras-GRF1 (aa 1^600, containing
PH1, IQ, DH-PH2 module) [13].
In the present paper we tested the ability of deletion mu-
tants of Ras-GRF1, to induce ERK signaling and activation
of the c-fos promoter in response to LPA. The results ob-
tained indicate that the N-terminal region of Ras-GRF1 span-
ning from the PH1 to the IQ (PCCQ) is necessary for the
LPA-induced activation of ERK1, but is dispensable for the
upregulation of the c-fos promoter. In addition parts of the
molecule containing the DH domain are capable to induce
gene transcription without activating ERK signaling. This ef-
fect may be due to the ability of the DH domain to activate c-
Jun NH2-terminal kinase (JNK) in a Rac-dependent manner.
This indicates that Ras-GRF1 belongs to a class of bifunc-
tional GEFs that can regulate both the Ras-Raf-ERK and the
Rho GTPases stress-activated protein kinase (SAPK) trans-
duction pathways [21].
2. Materials and methods
2.1. Plasmids and constructs
pHC21-VSV was obtained from pHC21 [13] by insertion of the
blunted 2.1 kb BamH1/EcoR1 fragment into a Sal1 digested and ¢lled
pMT2-VSV-G tag vector. The mutant resulted C-terminally tagged.
pDP-VSV was derived from pHC21-VSV by Pst1 digestion. The frag-
ment ampli¢ed by polymerase chain reaction (PCR) with oligonucleo-
tides 5P-catccggcttaacgatggccac-3P and 5P-ggaattcttccactttcgccggcac-3P,
was digested with EcoR1/Xho1 and inserted in a EcoR1/Xho1 digested
pHC21-VSV. The resulting construct was called pPCCQ. DH domain
ampli¢ed by PCR with oligonucleotides 5P-cgggatcccgaaagtggaagaa-
catcatccaggactacactcgg-3P and 5P-cggaattctcactggctggtgtccaggaggatct-
cacagcc-3P was digested with BamH1/EcoR1 and subcloned in a dou-
ble myc-tagged BamH1/EcoR1 digested pBS vector. The resulting N-
terminally myc-tagged DH domain was inserted by Sal1 digestion into
pMT2 expression vector. pMT2-GRF-HA is described in [22]. pMT2-
Mm1-HA was derived by subcloning the EcoR1 fragment of pMT2-
GRF-HA in the pMT2 vector. DPC was derived by insertion of
pHC21 Pst1/EcoR1 fragment in a pGEM-3Z containing the C-termi-
nal EcoR1 fragment of Ras-GRF. By partial Pst1 digestion and
blunted Xho1 digestion, the DPC was subcloned in a Pst1/Sma1 di-
gested pMT2 vector. The resulting plasmid was called pMT2-DPC.
pSRK-HA-JNK1 and pSRK-RacV12 were kindly provided by A.
Minden [23]. pGEX-c-Jun79, pCDNA3-Rac1N17 and pCDNA3-
Cdc42N17-HA were kindly provided by G. Scita (European Institute
of Oncology, Milan, Italy). pSG5-p85KvSH2-C was a gift from J.
Downward [24]. p44-HA was kindly provided by Pouyssegur [25].
pFos-luciferase was previously described [13].
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2.2. Cell cultures and transfections
NIH-3T3 and NIH-RG7 cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 10% newborn calf se-
rum. Cos-7 cells were cultured in DMEM supplemented with 10%
fetal bovine serum (FCS).
NIH-RG7 ¢broblasts, grown in 60-mm dishes, were transfected by
calcium phosphate method [13] keeping total DNA at 7 Wg per plate.
NIH-3T3 cells were cultured in 35-mm dishes and transfected using
the lipofectamine (GIBCO) method according to the protocol of the
manufacturer, keeping total DNA to 1.5 Wg per plate.
Subcon£uent Cos-7 cells were transfected by a standard DEAE-
dextran technique keeping total DNA to 5 Wg per 60-mm dish. In
all cases the day after transfection cells were serum starved for 24 h.
2.3. Luciferase assay
This assay was performed as described in [13], using Promega lucif-
erase assay system and the LUMAT LB 9501 E4030 (Berthold).
2.4. ERK kinase assays
Cells, transfected with p44-HA and with di¡erent constructs (as
described in the legends of the ¢gures), were stimulated with K-LPA
(Sigma) or left untreated, washed with ice-cold PBS and lysed in lysis
bu¡er as described by Crespo et al. [26]. The HA-tagged kinase was
immunoprecipitated from the cleared lysate with monoclonal anti-
HA-11 antibody (Babco). Immunocomplexes were recovered with
protein G-Sepharose (Sigma) and the MAPK activity was determined
in an in vitro kinase assay using myelin basic protein (MBP) as sub-
strate [26]. Aliquots of the in vitro assay were spotted on P81 paper
(Whatman) and the radioactivity was measured.
2.5. JNK kinase assay
Serum starved Cos-7 cells transfected with pSRK-HA-JNK1 and
pDP-VSV or pDH-Myc, were stimulated with K-LPA for 10 min
and lysed in the lysis bu¡er previously described [26]. The HA-tagged
kinase was immunoprecipitated with anti-HA-11 antibodies and the
JNK1 activity was measured using 2 Wg of puri¢ed GST-c-Jun (1^79)
fusion protein as substrate [27].
2.6. Detection of the proteins coded by the di¡erent constructs
Cells transfected with di¡erent constructs of Ras-GRF1 were lysed
as described above. Proteins were immunoprecipitated with Ras-GRF
antibodies and detected by Western blotting with the same antibodies.
Otherwise 25 Wg of total cell lysates or 1/50 of cleared cell lysates were
directly analyzed by Western blotting, using the di¡erent antibodies as
described in the legends of the ¢gures. Bound antibodies were visual-
ized with horseradish peroxidase-conjugated anti-rabbit or anti-mouse
antibodies using a chemiluminescent substrate (ECL, Amersham).
2.7. Antibodies
Anti-HA (11) and anti-myc (9E10) monoclonal antibodies (Babco),
anti-Ras-GRF (C-20), anti-ERK1 (K-23), and anti-p85K antibodies
(Santa Cruz), anti-VSV P5D4 monoclonal antibodies (Sigma), anti-
Rac1 antibodies (Transduction Laboratories) were used. Polyclonal
antibodies against the PH1 domain of Ras-GRF were raised in our
laboratory using the PH1 domain fused to the GST protein.
3. Results
3.1. PH1 and IQ domains of Ras-GRF1 are dispensable for
LPA-induced activation of gene transcription but are
essential for ERK signaling
In ¢broblasts ectopically expressing Ras-GRF1 (NIH-RG7)
activation of the c-fos promoter and of ERK1 is largely
stimulated by LPA and transient expression of the N-terminal
region (aa 1^600) of Ras-GRF1 strongly reduces the activa-
tion of the c-fos promoter [13]. To investigate the role of the
di¡erent domains present in the N-terminal region of Ras-
GRF1 (PH1, IQ, DH-PH2 module) we analyzed the ability
of several deletion mutants to activate the c-fos promoter and
ERK in response to LPA.
We genetically engineered two N-terminal deletion mu-
tants: the DPC mutant (aa 240^1262), lacking the ¢rst PH,
the coiled coil region and the IQ domain, and the Mm1 mu-
tant (aa 674^1262), lacking in addition the DH-PH2 module
(Fig. 1a). We then tested their ability to mediate the LPA-
induced c-fos promoter activation in comparison with the
entire Ras-GRF1. NIH-3T3 ¢broblasts were cotransfected
with either Ras-GRF1, or DPC or Mm1 together with the
c-fos-luciferase reporter gene and the luciferase activity was
assayed both in control and LPA-stimulated cells. The expres-
sion level of the three constructs was comparable (Fig. 1b).
For the experiments reported in Fig. 1c, transfections were
performed with low dosage of plasmids in order not to satu-
rate the system and to maintain it susceptible to further stim-
ulations. As shown in Fig. 1c luciferase activity in unstimu-
lated cells was the same in all the cases. A signi¢cant increase
Fig. 1. E¡ect of Ras-GRF1, DPC and Mm1 expression on the
LPA-induced activation of c-fos promoter in NIH-3T3 cells. a:
Schematic representation of Ras-GRF1, DPC and Mm1 mutants
highlighting functional domains. The plasmids carrying the di¡erent
constructs are described in Section 2. b: Expression of Mm1, DPC
and Ras-GRF1 in NIH-3T3 cells. NIH-3T3 cells were transfected
with pMT2-Mm1-HA (Mm1 mutant), pMT2-DPC (DPC mutant),
pMT2-GRF-HA (wt Ras-GRF1) or empty vector (as described in
Section 2). After 48 h the wild-type and mutants were immunopre-
cipitated from equal amounts of proteins of cellular lysates with
anti-Ras-GRF antibodies; the immunoprecipitates were subjected to
SDS-PAGE and immunoblot with anti-Ras-GRF antibodies. c:
NIH-3T3 cells grown in 35-mm dishes were cotransfected with 0.2
Wg of pMT2-GRF-HA, pMT2-DPC or pMT2-Mm1-HA and 0.33
Wg of pFos-luciferase. After serum withdrawal, cells were stimulated
with 10 WM LPA or left untreated. After 18 h cellular lysates were
prepared and analyzed for luciferase activity as described in Section
2. Each value is the mean þ S.E.M. derived from three independent
samples and is expressed as relative luciferase activity normalized
for the total protein content in the lysates. This is one of two inde-
pendent experiments performed in triplicates with similar results
(*P6 0.05).
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in luciferase activity was observed in cells transfected with
Ras-GRF1 and with DPC in response to LPA. Instead in cells
transfected with Mm1, as well as in control ones, LPA had no
e¡ect. Thus DPC, the construct including the DH-PH2 mod-
ule and the Ras-GEF domain (CDC25), seems to be su⁄cient
to upregulate the c-fos promoter.
We then tested the ability of the same DPC and Mm1
mutants to activate ERK1 in response to LPA. We cotrans-
fected in NIH-3T3 cells either Ras-GRF1, or DPC or Mm1
together with the HA-tagged ERK1 (p44-HA). The kinase
was immunoprecipitated from either unstimulated or LPA-
treated cells and its activation was then evaluated in an in
vitro kinase assay. As shown in Fig. 2, without stimulation
the activity of ERK1 was the same in cells transfected with
the vector or with the di¡erent constructs. However 5 min
stimulation with LPA induced a strong activation of ERK1
in Ras-GRF1 transfected cells, but only minor e¡ects in cells
transfected with vector, DPC or Mm1. The same results were
obtained by probing immunoprecipitated ERK1 with antibod-
ies against phosphorylated MAPKs (not shown). Also in these
experiments intentionally low dosage of the di¡erent con-
structs was used to maintain the ERK cascade more suscep-
tible to external stimuli. The data of Fig. 2 demonstrate that
the extreme N-terminal region of Ras-GRF1 (PH1, coiled
coil, IQ) is essential for the activation of ERK1 by LPA.
An independent con¢rmation of this ¢nding comes from the
following experiment. Di¡erent constructs (pHC21-VSV,
pPCCQ, pDP-VSV) coding respectively for products spanning
aa 1^630, 1^240 and 240^630 of wild-type Ras-GRF1 (Fig. 3a
and b) were cotransfected together with p44-HA in NIH-RG7
¢broblasts which overexpress Ras-GRF1. Following a 5 min
stimulation with LPA the kinase was immunoprecipitated and
its activity was determined. As shown in Fig. 3c, the ERK1
activity measured in the absence of LPA was not modi¢ed by
the expression of the three mutants. Instead both the entire N-
terminal region (aa 1^630) and the PCCQ protein, which con-
tains the PH1, the coiled coil and the IQ domain, reduced the
LPA-induced ERK1 activation in NIH-RG7 cells, thus acting
as dominant negative mutants. On the contrary the DH-PH2
module (aa 240^630) did not exert negative e¡ects. The mu-
tants were expressed in ¢broblasts at similar level (Fig. 3b)
and, as Ras-GRF1, all of them were preferentially localized in
the membrane fraction (data not shown). In NIH-3T3 cells
these mutants did not interfere with the basal or the PDGF-
Fig. 2. E¡ect of Ras-GRF1 and N-terminal deletion mutants on
LPA-induced ERK1 activation in NIH-3T3 cells. NIH-3T3 cells
grown in 35-mm dishes were cotransfected with 0.2 Wg pMT2-GRF-
HA, pMT2-DPC or pMT2-Mm1-HA and 0.5 Wg of p44-HA (HA-
tagged ERK1). After serum withdrawal, cells were stimulated with
3 WM LPA for 5 min or left untreated. ERK1 was immunoprecip-
itated from cellular lysates and ERK activity tested in an in vitro
assay. Results represent the mean þ S.E.M. from four independent
samples. ERK1 immunoprecipitated from parallel plates was sepa-
rated by SDS-PAGE and immunoblotted with anti-ERK1 antibod-
ies.
Fig. 3. E¡ect of pertussis toxin and of the expression of N-terminal
regions of the Ras-GRF1 on the LPA-induced ERK1 activation in
¢broblasts overexpressing Ras-GRF1. a: Schematic diagram of N-
terminal mutants depicted as in Fig. 1a. b: Expression of the mu-
tants of Ras-GRF1 described in a. Equal amounts of proteins from
total lysates of NIH-3T3 cells transiently transfected with pHC21-
VSV, pDP-VSV or pPCCQ (see Section 2 for the details) were sepa-
rated by SDS-PAGE and immunoblotted with anti-VSV or anti-
PH1 of Ras-GRF antibodies. c: NIH-RG7 cells that stably overex-
press Ras-GRF1 were transfected with 5 Wg of the constructs de-
scribed above together with 2 Wg of HA-tagged ERK1 (see Section
2). After serum starvation cells were stimulated with 10 WM LPA
for 5 min or left untreated. When indicated NIH-RG7 transfected
with vector alone were treated for 5 h with pertussis toxin (100 ng/
ml) and then stimulated as above with LPA. ERK1 was immuno-
precipitated from cell lysates and its activity assayed with myelin
basic protein as substrate. The kinase activity of cells transfected
with an empty vector (marked vector) and not stimulated was set to
1. Results represent the mean þ S.E.M. from four to six independent
samples (*P6 0.01 with respect to vector plus LPA). Immunoprecip-
itated ERK1 from parallel plates was separated by SDS-PAGE and
immunoblotted with anti-ERK1 antibodies.
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induced c-fos promoter activity ([13], and data not shown),
thus ruling out possible aspeci¢c inhibitory e¡ects.
Taken together these data demonstrate that the ability of
Ras-GRF1 to potentiate LPA signaling via ERK activation is
dependent on the PCCQ region. On the other hand the DH-
PH2 module seems to be essential for activating gene tran-
scription in absence of signi¢cant potentiation of ERK signal-
ing.
In the same ¢gure it is also shown that in NIH-RG7 cells
the e¡ect of LPA on ERK1 activation is inhibited by pretreat-
ment with pertussis toxin, indicating the involvement of Gi
protein-coupled receptors, as already reported for other re-
sponses to LPA in these cells [13].
3.2. The isolated DH-PH2 module of Ras-GRF1 activates in
vivo JNK1 and the c-fos promoter
Activation of Rac/Cdc42 members of the Rho family of
small GTPases by Dbl-like GEFs can lead to induction of
the c-Jun NH2-terminal kinase (JNK1) activity [16]. We
thus considered the hypothesis that the DH domain might
activate JNK1 and thus cooperate in the induction of gene
expression. Therefore we cotransfected an epitope-tagged
JNK1 together with Ras-GRF1 in Cos-7 cells. The activity
of JNK was then tested in vitro using as substrate a gluta-
thione S-transferase-c-Jun fusion protein (GST-c-Jun).
As shown in Fig. 4b, the expression of Ras-GRF1 signi¢-
cantly increased JNK1 activity, and LPA further stimulated it.
Moreover both the isolated DH domain and DH-PH2 module
had a similar e¡ect on the LPA-stimulated JNK1 activity, and
the DH-PH2 module increases the JNK1 activity also in the
absence of exogenous stimuli. Cotransfection with the domi-
nant negative allele of Rac1 (RacN17) greatly reduced the
Fig. 4. E¡ect of Ras-GRF1, DH-PH2 and DH on JNK1 activity. a: Schematic diagram of DH-PH2 and DH mutants depicted as in Fig. 1a.
b: Cos-7 cells were cotransfected with 1 Wg of pSRK-HA-JNK1 together with 3 Wg of pDP-VSV (DH-PH2) or pDH-Myc (DH) or 3 Wg of
pMT2-GRF-HA. After 18 h serum starvation, cells were stimulated with 10 WM LPA for 10 min or left untreated. The tagged kinase was im-
munoprecipitated with anti-HA antibodies. JNK1 activity in the immunocomplexes was measured using GST-c-Jun as substrate (as described
in Section 2). The basal kinase activity of samples from cells transfected with the empty vector (marked vector) was set to 1. Results represent
the mean þ S.E.M. from four independent samples. The experiment was repeated three times with similar results (**P6 0.01 with respect to vec-
tor; *P6 0.05 with respect to vector plus LPA). Aliquots of lysates and immunoprecipitates were subjected to SDS-PAGE and Western blot-
ting with anti-Ras-GRF, anti-myc (for DH expression), anti-VSV (for DH-PH2 expression) or anti-HA (for JNK1) antibodies.
Fig. 5. E¡ect of RacN17, Cdc42N17 on the DH-PH2-mediated
JNK1 activation. Cos-7 cells were cotransfected with 1 Wg of pSRK-
HA-JNK1, 3 Wg of pDP-VSV (DH-PH2) and with 1 Wg of
pCDNA3-Rac1N17 or pCDNA3-Cdc42N17-HA. After 18 h in the
absence of serum the kinase activity was determined as above. The
basal kinase activity of samples from cells transfected with an empty
vector (marked vector) was set to 1. Results represent the mean þ
S.E.M. from three independent samples. Aliquots of lysates and im-
munoprecipitates were subjected to SDS-PAGE and Western blot-
ting with anti-HA (for Cdc42N17 expression), anti-Rac1 (for
Rac1N17 expression) or anti-HA (for JNK1) antibodies.
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activation of JNK1 induced by DH-PH2, while Cdc42N17
had no e¡ect on it, even when the plasmid concentration
was doubled (not shown) (Fig. 5). This result suggests that
the DH-PH2-induced JNK1 activation may be mediated by
Rac, in accordance with the report of Kiyono et al. [20].
It was recently shown that interaction of phosphatidylino-
sitol [3,4,5]-Tris-phosphate with the PH domain of DH-PH
modules of Sos and Vav, upregulated the Rac-GEF activity
of these proteins [17,28]. We cotransfected Cos-7 cells with
JNK1, the DH-PH2 module of Ras-GRF1 and a dominant
negative PI3-K p85 adaptor subunit, which abrogates the ac-
tivity of PI3-K [24]. We found (Fig. 6) that the basal activity
of control and DH-PH2 transfected cells was not a¡ected by
p85 dominant negative (p85DN) and similar results were ob-
tained with wortmannin (not shown). Instead p85DN reduced
LPA-induced JNK1 activity, both in control cells and in cells
transfected with DH-PH2 module. These results indicate that
the stimulation of Rac/JNK pathway by DH-PH2 does not
require the activity of p85/p110 PI3-K, while the e¡ect of LPA
does.
The isolated DH-PH2 module, transfected in NIH-3T3
cells, was able to activate the c-fos promoter in response to
LPA, to an extent comparable to the entire Ras-GRF1 mol-
ecule, while it had no signi¢cant e¡ect on the basal activity
(Fig. 7). These results further support a role for the DH-PH2
module of Ras-GRF1 in modulating gene expression.
4. Discussion
Ras-GEFs such as Ras-GRF1, Ras-GRF2 and Sos proteins
exhibit a modular structure [1,5,7]. In Ras-GRFs, domains
localized at the N-terminal moiety of the molecule might
play diverse roles such as allowing protein/protein or pro-
tein/lipid interactions, providing autoregulatory mechanisms
or other catalytic activities in addition to the Ras-GEF activ-
ity of the C-terminal domain. However the in vivo functions
of such additional domains are not yet fully understood. To
investigate the role of these domains we tested di¡erent con-
structs of Ras-GRF1 for their ability to mediate responses to
LPA.
We found that the DPC mutant, in which the ¢rst PH
domain, the coiled coil and the calcium calmodulin-binding
IQ domain were deleted (but the DH-PH2 module and the
Ras-GEF catalytic domain were maintained), was impaired in
the LPA-induced activation of ERK1. Moreover the PCCQ
mutant (PH1 through IQ), when expressed in trans, was found
to inhibit the LPA-induced activation of ERK1 in ¢broblasts
stably overexpressing Ras-GRF1. This e¡ect might be due to
competition for signaling molecules activated by LPA: the
calcium-calmodulin complex [11] and G protein LQ subunits
[20] are the most likely candidates. In fact pertussis toxin,
inhibitor of G1 proteins, abolishes the e¡ect of LPA on
ERK activation in NIH-RG7 cells. Moreover Kiyono et al.
[20] recently reported that LQ complex potentiates Ras-GRF1
e¡ect on ERK activity, the ¢rst PH domain being essential for
this e¡ect.
Others [14] suggest that activation of Ras-GRF1 by LPA
requires an increase of calcium and a phosphorylation event.
Thus the e¡ect of LPA on the Ras-GRF1-dependent activa-
tion of ERK should be the result of LQ release and possibly
interaction with Ras-GRF1 [29], increase in calcium (acting
Fig. 6. E¡ect of p85DN on the DH-PH2-mediated JNK1 activation.
Cos-7 cells were cotransfected with 1 Wg of pSRK-HA-JNK1, 3 Wg
of pDP-VSV (DH-PH2) and with 1.5 Wg of pSG5-p85KvSH2-C
(p85DN). After 18 h serum starvation, cells were stimulated with 10
WM LPA for 10 min or left untreated. The kinase activity was de-
termined as above. The basal kinase activity of samples from cells
transfected with an empty vector (marked vector) was set to 1. Re-
sults represent the mean þ S.E.M. from three independent samples
and the experiment was repeated two times with similar results. Ali-
quots of lysates and immunoprecipitates were subjected to SDS-
PAGE and Western blotting with anti-p85K (for p85DN expression)
or anti-HA (for JNK1) antibodies.
Fig. 7. E¡ect of DH-PH2 expression on the LPA-induced activation
of c-fos promoter in NIH-3T3 cells. NIH-3T3 cells were transfected
with the di¡erent constructs (0.2 Wg of pMT2-GRF-HA or 1 Wg
pDP-VSV) together with 0.11 Wg pFos-luciferase and treated as de-
scribed in Fig. 1c. Luciferase activity was then determined. Each
value is the mean þ S.E.M. derived from three independent samples
and is expressed as relative luciferase activity normalized for the to-
tal protein content in the lysates. This is one of two independent ex-
periments performed in triplicates with similar results (*P6 0.05).
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on Ras-GRF1 in complex with calmodulin (Zippel et al., sub-
mitted)) and a phosphorylation. With regard to the e¡ect of
calcium ionophores on ERK, it has been reported that intact
DH and PH2 domains are essential for this response [19,30]
while phosphorylation of Ras-GRF1 does not occur [14].
On the other hand the DPC mutant, unable to mediate
LPA signaling on ERK, behaves in the same way as the entire
molecule in activating the c-fos promoter, a downstream tar-
get of di¡erent signaling pathways [31], in response to stim-
ulation with LPA. The Mm1 construct (which in addition to
the PCCQ also lacks the DH-PH2 module) is unable to do so.
Thus the Ras-GRF1-mediated long term e¡ects of LPA re-
quire the presence of DH-PH2 module (but do not need the
PCCQ region), and in fact the isolated DH-PH2 module is
able to activate c-fos in response to LPA.
These observations suggest that activation of the c-fos pro-
moter can occur in the absence of hyperactivation Ras-ERK
pathway. Anyway in NIH-3T3 cells even in the absence of
Ras-GRF1, LPA induces a certain activation of ERK possi-
bly through the Sos exchange factor [3] and this might con-
tribute to the observed e¡ects.
The e¡ect of isolated DH-PH2 module on gene transcrip-
tion may be explained by the ¢nding that the same module
activates JNK1, as also does the entire Ras-GRF1 molecule,
and this e¡ect is further stimulated by LPA. In accordance
with this ¢nding it has very recently been reported that Ras-
GRF1 activates JNK1, that this e¡ect is potentiated by LQ and
that the DH domain is essential for this e¡ect [20].
The activation of JNK1 by the isolated DH-PH2 appears to
be mediated by the small GTPase Rac, does not need the
activity of PI3K and, since it takes place in the absence of
the catalytic domain of Ras-GRF1 and without stimuli, does
not seem to require an activated Ras. We found that while the
e¡ect of both the isolated DH domain and the DH-PH2 mod-
ule can be potentiated by LPA, isolated DH displays no con-
stitutive activity. Thus regulation of the DH domain of Ras-
GRF1 seems rather di¡erent from that of the DH of Sos1
[17]. Moreover the data suggest that the e¡ect of LPA on
Ras-GRF1-mediated JNK1 activation passes through a regu-
lation of the DH domain.
In conclusion this work supports the view that, in response
to LPA, Ras-GRF1 acts as a bifunctional exchange factor
activating Ras/ERK pathway through its Ras-GEF domain
and Rac/JNK pathway through DH-PH2 module.
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